Purpose of the Laboratory Tests

As part of my long-term research into the impact of artificial reality on human biology, I have conducted a comprehensive series of clinical blood tests spanning several years. This work focuses especially on individuals—beginning with myself—who have undergone prolonged exposure to substances such as nicotine, caffeine, sugar, alcohol, and petroleum-based products. These compounds all share a common biochemical trait: they contain methyl groups, which influence how they are processed by the body through a pathway known as methylation.

Methylation is a critical biochemical process that affects gene expression, detoxification, neurological function, and more. When artificial substances with methyl groups are chronically consumed, they can interfere with natural metabolic cycles, alter neurochemical balance (particularly dopamine), and distort the body’s homeostasis. This, I argue, is one of the key mechanisms behind what I call “artificial reality”—a chemically induced cognitive and physiological state disconnected from our biological baseline.

To investigate these effects in a rigorous, transparent, and scientifically valid way, I subjected myself to repeated laboratory testing. These tests measure biomarkers related to liver function, inflammation, metabolism, neurotransmitters, and other key indicators affected by methylation pathways. The goal is to document the long-term physiological consequences of exposure to these substances, and to provide empirical data that can support future therapeutic models—potentially even antidotes—to restore balance and mitigate dependency.

In accordance with scientific protocols for evaluating new treatments or interventions, I believe it is essential not only to present conclusions, but to show the data behind them: dates, methodologies, test types, and biological markers. This level of transparency and accountability is what defines responsible research.

The test results shared here are part of a broader commitment to validating knowledge through evidence. They are also a call for deeper inquiry into how common substances, widely accepted and normalized, shaping both individual and collective health in ways science is  running business with Pharma.